PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32210737-0	2020	Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.	Cisplatin	31-40	ZEB1 antisense RNA 1	Homo sapiens	14-22	
32210737-0	2020	Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.	Cisplatin	31-40	microRNA 1295a	Homo sapiens	83-98	
32210737-0	2020	Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.	Cisplatin	31-40	zinc finger E-box binding homeobox 1	Homo sapiens	14-18	
32210737-13	2020	Besides, drug resistance to cisplatin was inhibited, and cell apoptosis was promoted in breast cancer after transfection of miR-129-5p mimic, lncRNA ZEB1-AS1 siRNA, and ZEB1 siRNA.	Cisplatin	28-37	zinc finger E-box binding homeobox 1	Homo sapiens	169-173